David P. Al-Adra, MD, PhD, FACS

Assistant Professor

  • Division of Transplantation 

aladra@surgery.wisc.edu
(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792

Education

  • MD, University of Alberta, 2007
  • PhD, Clinical Investigator Program in the Department of Surgery, University of Alberta, 2012
  • Residency, General Surgery, University of Alberta, 2015
  • Abdominal Organ Transplant Fellowship, University of Toronto, 2017

Clinical Specialties

Dr. Al-Adra is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), the Royal College of Surgeons of Canada, and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Al-Adra is investigating the mechanisms of immunological rejection after solid organ transplantation. The goal of his research is to decrease the immune response against the organ, which would then decrease the need for anti-rejection drugs. Specifically, the transplanted organs can be modified using normothermic machine organ preservation technologies to decrease rejection after transplantation.

Learn more about Dr. Al-Adra’s lab here. 

Recent Publications

  • Five Critical Gene-Based Biomarkers With Optimal Performance for Hepatocellular Carcinoma.
    Liu Y, Zhang H, Xu Y, Liu YZ, Al-Adra DP, Yeh MM, Zhang Z
    Cancer Inform 2023; 22: 11769351231190477
    [PubMed ID: 37577174]

  • A Randomized Controlled Trial of Envarsus Versus Immediate Release Tacrolimus in Kidney Transplant Recipients With Delayed Graft Function.
    Parajuli S, Muth B, Bloom M, Ptak L, Aufhauser D, Thiessen C, Al-Adra D, Mezrich J, Neidlinger N, Odorico J, Wang JG, Foley D, Kaufman D, Mandelbrot DA
    Transplant Proc 2023 Sep; 55(7): 1568-1574
    [PubMed ID: 37394382]

  • Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States - A Randomized Controlled Trial.
    Chapman WC, Barbas AS, D'Alessandro AM, Vianna R, Kubal CA, Abt P, Sonnenday C, Barth R, Alvarez-Casas J, Yersiz H, Eckhoff D, Cannon R, Genyk Y, Sher L, Singer A, Feng S, Roll G, Cohen A, Doyle MB, Sudan DL, Al-Adra D, Khan A, Subramanian V, Abraham N, Olthoff K, Tekin A, Berg L, Coussios C, Morris C, Randle L, Friend P, Knechtle SJ
    Ann Surg 2023 Jun 26;
    [PubMed ID: 37389552]

  • Quantifying the immune response to a tissue-engineered porcine extracellular matrix.
    El-Andari R, Bozso SJ, Jh Kang J, Fialka NM, Al-Adra D, Meyer SR, Moon MC, Freed DH, Nagendran J, Nagendran J
    Regen Med 2023 Mar; 18(3): 229-237
    [PubMed ID: 36691822]

  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Bhat M, Dondossola D, Varghese R, Czigany Z, Emamaullee J, Ghinolfi D, Al-Adra D, Bonaccorsi-Riani E, Pang L, Boteon YL, Brüggenwirth I, Pavan-Guimaraes J, Ho CM, Yuksel M, Zarrinpar A, Abdelrahim M, Barbas AS, Mas V, Selzner M, Martins PN
    Transplantation 2023 Apr 01; 107(4): 808-814
    [PubMed ID: 36550624]

All Publications on PubMed